Phase II trial of ONO-4053 for the treatment of allergic rhinitis in Japan

Trial Profile

Phase II trial of ONO-4053 for the treatment of allergic rhinitis in Japan

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Mar 2016

At a glance

  • Drugs ONO 4053 (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Mar 2016 Results assessing effect of ONO-4053 on mast cell activation presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 19 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top